Status:

RECRUITING

Interest of tDCS in Help for Supporting Alcohol Abstinence

Lead Sponsor:

Centre Hospitalier Henri Laborit

Conditions:

Alcoholic Intoxication

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

The aim of the study is to evaluate in patients with alcohol disorder and forehand weaned the efficiency of 10 active tDCS sessions versus 10 sham (placebo) sessions in the support of abstinence at 3 ...

Detailed Description

The study takes place at one site (Henri Laborit Hospital, Poitiers, France) and is comparative, randomized and controlled. There are 2 groups : one group is receiving sessions of active tDCS (active...

Eligibility Criteria

Inclusion

  • patient aged from 18 to 70 years old
  • patient free, without guardianship
  • absence of epileptic pathology
  • patient affiliated to the french health security or benefiting through a third party
  • signed informed consent after having received a clear and honest information on the study.
  • patient with a disorder linked to the use of alcohol (define by the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) classification) clinically evaluated.
  • patient requesting for an alcohol withdrawal
  • patient able to read and write

Exclusion

  • patient not affiliated to the french health security or not benefiting through a third party
  • woman in reproductive capacity without effective contraception (hormonal/mechanical: per os, injectable, transcutaneous, implantable, intra-uterine device or chirurgical: tubal ligation, hysterectomy, total ovariectomy) or breastfeeding
  • patient hospitalized under duress
  • patient with guardianship
  • somatic complications during the alcohol withdrawal phase
  • current psychiatric decompensation (mood disorder, suicide risk, psychotic disorders).
  • patient under benzodiazepines treatment
  • patient with scalp cutaneous lesion
  • history of cranial traumatism
  • patient with intra-cerebral metallic object
  • patient with a pacemaker
  • epileptic pathology
  • patient in emergency condition or unable to give personally her/his consent
  • another dependence other than alcohol or tobacco
  • mental illness syndrome and Korsakoff

Key Trial Info

Start Date :

February 8 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 1 2025

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT03287154

Start Date

February 8 2017

End Date

November 1 2025

Last Update

June 5 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Centre Hospitalier Henri Laborit

Poitiers, France

2

Centre Hospitalier Nord-Deux-Sèvres

Thouars, France